Clover Health Investments (CLOV) Short-term Investments (2021 - 2026)

Clover Health Investments has reported Short-term Investments for 6 years, with the latest figure at $24.2 million in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments rose 419.54% year-over-year to $24.2 million; the trailing twelve-month figure through Mar 2026 stood at $24.2 million (up 419.54% YoY), and the FY2025 full-year result was $1.8 million, up 11746.67% from the prior year.
• Short-term Investments for Q1 2026 stood at $24.2 million, up from $1.8 million in the prior quarter.
• The five-year high for Short-term Investments was $189.5 million in Q4 2022, with the low at $15000.0 in Q4 2024.
• Historically, Short-term Investments has averaged $51.7 million across 5 years, with a median of $12.2 million in 2023.
• Annual changes were most pronounced in 2024 — Short-term Investments slumped 99.88% — and 2025, when it surged 11746.67%.
• Clover Health Investments' Short-term Investments stood at $189.5 million in 2022, then slumped by 93.55% to $12.2 million in 2023, then tumbled by 99.88% to $15000.0 in 2024, then surged by 11746.67% to $1.8 million in 2025, then soared by 1261.28% to $24.2 million in 2026.
• The last three Short-term Investments figures came in at $24.2 million (Q1 2026), $1.8 million (Q4 2025), and $11.0 million (Q3 2025), per Business Quant data.